MedPath

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Conditions
Osteoarthritis of the Hip
Registration Number
NCT00951145
Lead Sponsor
Rothman Institute Orthopaedics
Brief Summary

This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem.
  2. Patients with hip fracture undergoing THA will also be included.
  3. Patients willing and able to comply with follow-up requirements and self-evaluations.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem
Secondary Outcome Measures
NameTimeMethod
Proximally coated tapered stems can be used for patients with various bone types, bone morphology, and underlying diagnosis

Trial Locations

Locations (1)

Rothman Institute

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath